Literature DB >> 9712751

Acute Plasmodium chabaudi chabaudi malaria infection induces antibodies which bind to the surfaces of parasitized erythrocytes and promote their phagocytosis by macrophages in vitro.

M M Mota1, K N Brown, A A Holder, W Jarra.   

Abstract

CBA/Ca mice infected with 5 x 10(4) Plasmodium chabaudi chabaudi AS-parasitized erythrocytes experience acute but self-limiting infections of relatively short duration. Parasitemia peaks ( approximately 40% infected erythrocytes) on day 10 or 11 and is then partially resolved over the ensuing 5 to 6 days, a period referred to as crisis. How humoral and cellular immune mechanisms contribute to parasite killing and/or clearance during crisis is controversial. Humoral immunity might be parasite variant, line, or species specific, while cellular immune responses would be relatively less specific. For P. c. chabaudi AS, parasite clearance is largely species and line specific during this time, which suggests a primary role for antibody activity. Accordingly, acute-phase plasma (APP; taken from P. c. chabaudi AS-infected mice at day 11 or 12 postinfection) was examined for the presence of parasite-specific antibody activity by enzyme-linked immunosorbent assay. Antibody binding to the surface of intact, live parasitized erythrocytes, particularly those containing mature (trophozoite and schizont) parasites, was demonstrated by immunofluorescence in APP and the immunoglobulin G (IgG)-containing fraction thereof. Unfractionated APP (from P. c. chabaudi AS-infected mice), as well as its IgG fraction, specifically mediated the opsonization and internalization of P. c. chabaudi AS-parasitized erythrocytes by macrophages in vitro. APP from another parasite line (P. c. chabaudi CB) did not mediate the same effect against P. c. chabaudi AS-parasitized erythrocytes. These results, which may represent one mechanism of parasite removal during crisis, are discussed in relation to the parasite variant, line, and species specificity of parasite clearance during this time.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9712751      PMCID: PMC108489          DOI: 10.1128/IAI.66.9.4080-4086.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Use of a DNA probe to analyse the dynamics of infection with rodent malaria parasites confirms that parasite clearance during crisis is predominantly strain- and species-specific.

Authors:  G Snounou; W Jarra; S Viriyakosol; J C Wood; K N Brown
Journal:  Mol Biochem Parasitol       Date:  1989-11       Impact factor: 1.759

2.  Protective immunity to malaria. Studies with cloned lines of Plasmodium chabaudi chabaudi and P. berghei in CBA/Ca mice. II. The effectiveness and inter- or intra-species specificity of the passive transfer of immunity with serum.

Authors:  W Jarra; L A Hills; J C March; K N Brown
Journal:  Parasite Immunol       Date:  1986-05       Impact factor: 2.280

3.  Plasmodium chabaudi: antigenic variation during recrudescent parasitaemias in mice.

Authors:  S A McLean; C D Pearson; R S Phillips
Journal:  Exp Parasitol       Date:  1982-12       Impact factor: 2.011

4.  Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa.

Authors:  B M Greenwood; A K Bradley; A M Greenwood; P Byass; K Jammeh; K Marsh; S Tulloch; F S Oldfield; R Hayes
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

5.  An analysis of the relationship of host factors to clinical falciparum malaria by multiple regression techniques.

Authors:  G Pazzaglia; W E Woodward
Journal:  Am J Trop Med Hyg       Date:  1982-03       Impact factor: 2.345

6.  Differential T cell responses to Plasmodium chabaudi chabaudi in peripheral blood and spleens of C57BL/6 mice during infection.

Authors:  J Langhorne; B Simon-Haarhaus
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

7.  Two approximately 300 kilodalton Plasmodium falciparum proteins at the surface membrane of infected erythrocytes.

Authors:  R J Howard; J W Barnwell; E P Rock; J Neequaye; D Ofori-Adjei; W L Maloy; J A Lyon; A Saul
Journal:  Mol Biochem Parasitol       Date:  1988-01-15       Impact factor: 1.759

8.  Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium.

Authors:  G M Jeffery
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

9.  Protective immunity to malaria: studies with cloned lines of rodent malaria in CBA/Ca mice. IV. The specificity of mechanisms resulting in crisis and resolution of the primary acute phase parasitaemia of Plasmodium chabaudi chabaudi and P. yoelii yoelii.

Authors:  W Jarra; K N Brown
Journal:  Parasite Immunol       Date:  1989-01       Impact factor: 2.280

10.  Protective immunity to malaria: studies with cloned lines of Plasmodium chabaudi and P. berghei in CBA/Ca mice. I. The effectiveness and inter- and intra-species specificity of immunity induced by infection.

Authors:  W Jarra; K N Brown
Journal:  Parasite Immunol       Date:  1985-11       Impact factor: 2.280

View more
  33 in total

1.  Variant-specific immunity to Plasmodium berghei in pregnant mice.

Authors:  Rosette Megnekou; Lars Hviid; Trine Staalsoe
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

2.  A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.

Authors:  A Rainczuk; T Scorza; T W Spithill; P M Smooker
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

3.  Pretreatment with Cry1Ac protoxin modulates the immune response, and increases the survival of Plasmodium-infected CBA/Ca mice.

Authors:  Martha Legorreta-Herrera; Rodrigo Oviedo Meza; Leticia Moreno-Fierros
Journal:  J Biomed Biotechnol       Date:  2010-03-11

4.  VEGF promotes malaria-associated acute lung injury in mice.

Authors:  Sabrina Epiphanio; Marta G Campos; Ana Pamplona; Daniel Carapau; Ana C Pena; Ricardo Ataíde; Carla A A Monteiro; Nuno Félix; Artur Costa-Silva; Claudio R F Marinho; Sérgio Dias; Maria M Mota
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

5.  Antibody isotype analysis of malaria-nematode co-infection: problems and solutions associated with cross-reactivity.

Authors:  Karen J Fairlie-Clarke; Tracey J Lamb; Jean Langhorne; Andrea L Graham; Judith E Allen
Journal:  BMC Immunol       Date:  2010-02-17       Impact factor: 3.615

6.  Insights into the preclinical treatment of blood-stage malaria by the antibiotic borrelidin.

Authors:  I G Azcárate; P Marín-García; N Camacho; S Pérez-Benavente; A Puyet; A Diez; L Ribas de Pouplana; J M Bautista
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

Review 7.  A bite to fight: front-line innate immune defenses against malaria parasites.

Authors:  Stephanie Tannous; Esther Ghanem
Journal:  Pathog Glob Health       Date:  2018-01-29       Impact factor: 2.894

8.  Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa.

Authors:  Issa Nebie; Amidou Diarra; Alphonse Ouedraogo; Issiaka Soulama; Edith C Bougouma; Alfred B Tiono; Amadou T Konate; Roma Chilengi; Michael Theisen; Daniel Dodoo; Ed Remarque; Samuel Bosomprah; Paul Milligan; Sodiomon B Sirima
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

9.  Induction of specific T-cell responses, opsonizing antibodies, and protection against Plasmodium chabaudi adami infection in mice vaccinated with genomic expression libraries expressed in targeted and secretory DNA vectors.

Authors:  A Rainczuk; T Scorza; P M Smooker; T W Spithill
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

10.  The dynamics of acute malaria infections. I. Effect of the parasite's red blood cell preference.

Authors:  Rustom Antia; Andrew Yates; Jacobus C de Roode
Journal:  Proc Biol Sci       Date:  2008-06-22       Impact factor: 5.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.